2-Hydroxypropyl-beta-cyclodextrin
"2-Hydroxypropyl-beta-cyclodextrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator.
| Descriptor ID |
D000073738
|
| MeSH Number(s) |
D04.345.103.333.500 D09.301.915.400.375.333.500 D09.698.365.855.400.375.333.500
|
| Concept/Terms |
2-Hydroxypropyl-beta-cyclodextrin- 2-Hydroxypropyl-beta-cyclodextrin
- 2 Hydroxypropyl beta cyclodextrin
- beta-Hydroxypropylcyclodextrin
- beta Hydroxypropylcyclodextrin
- HPbetaCD
- Hydroxypropyl Betadex
- Betadex, Hydroxypropyl
- HP-beta-CD
- 2 Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl beta cyclodextrin
|
Below are MeSH descriptors whose meaning is more general than "2-Hydroxypropyl-beta-cyclodextrin".
Below are MeSH descriptors whose meaning is more specific than "2-Hydroxypropyl-beta-cyclodextrin".
This graph shows the total number of publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in this website by year, and whether "2-Hydroxypropyl-beta-cyclodextrin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in Profiles.
-
Enhanced oral bioavailability and anticancer efficacy of fisetin by encapsulating as inclusion complex with HP?CD in polymeric nanoparticles. Drug Deliv. 2017 Nov; 24(1):224-232.
-
Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51.
-
2-Hydroxypropyl-?-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J Biol Chem. 2014 Apr 04; 289(14):10211-22.
-
Anxiolytic effects and neuroanatomical targets of estrogen receptor-? (ER?) activation by a selective ER? agonist in female mice. Endocrinology. 2012 Feb; 153(2):837-46.
-
Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes. Pharm Res. 2003 Oct; 20(10):1626-33.
-
Phase I bioequivalency study of MitoExtra and mitomycin C in patients with solid tumors. Cancer. 2001 Feb 15; 91(4):815-21.
-
Cholesterol efflux-mediated signal transduction in mammalian sperm. beta-cyclodextrins initiate transmembrane signaling leading to an increase in protein tyrosine phosphorylation and capacitation. J Biol Chem. 1999 Jan 29; 274(5):3235-42.